(Q77378845)

English

Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma

scientific article published on 01 December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

F Zallio

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Vallet

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

I Ricca

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A Cuttica

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

D Caracciolo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

P Corradini

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Astolfi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Sametti

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

F Volpato

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

P Bondesan

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Boccadoro

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A Pileri

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A M Gianni

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

C Tarella

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1941-1949

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753616%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402302

0 references

Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA vaccines against cancer: from genes to therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of rituximab, the new FDA-approved antibody.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquired IgA deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402302

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77378845&oldid=2046894779"